| KEGG terms | Input genes |
| Fc gamma R-mediated phagocytosis | AKT2, PIK3R5, SPHK1, PIP5K1A, LAT, FCGR3A, GSN, CFL1, DNM2 | Tuberculosis | CTSD, SPHK1, FCGR3A, CIITA, ITGB2, CAMK2D, MRC2, RFX5, ATP6V0C, ATP6V0A1, MYD88, HLA-DMA, AKT2 | Synaptic vesicle cycle | ATP6V0E2, DNM3, ATP6V0C, NAPA, ATP6V0A1, CLTA, DNM2 | Lysosome | CLN3, CTSD, PPT2, GBA, ATP6V0C, TPP1, SLC11A2, ATP6V0A1, CLTA, GGA1 | Natural killer cell-mediated cytotoxicity | NFATC1, SH3BP2, LAT, ITGB2, FAS, PIK3R5, GZMB, FCGR3A, LCK | HTLV-I infection | CCND3, TCF3, CRTC1, NFATC1, NFATC3, HLA-DMA, XPO1, ITGB2, PIK3R5, CHEK2, ANAPC11, LCK, AKT2, POLD2 | Bacterial invasion of epithelial cells | FN1, DNM3, SEPT9, PIK3R5, CLTA, DNM2 | mTOR signaling pathway | TSC2, STRADA, PIK3R5, AKT2, MLST8 | Influenza A | CIITA, HLA-DMA, XPO1, FAS, PIK3R5, DDX39B, IRF3, NXF1, MYD88, AKT2 | Apoptosis | FAS, PIK3R5, PRKAR1B, MYD88, CAPN1, AKT2 | Collecting duct acid secretion | ATP6V0E2, ATP6V0C, ATP6V0A1 | mRNA surveillance pathway | NXF1, ACIN1, SMG7, DDX39B, PABPC1L, PABPC1 | Pertussis | IRF1, MYD88, ITGB2, IRF3, CFL1 | Fanconi anemia pathway | FANCM, BRCA1, FANCI, TOP3A | Base excision repair | MUTYH, POLD2, XRCC1 | Proteoglycans in cancer | FN1, FLNA, ANK1, RDX, FAS, CAMK2D, PIK3R5, CD44, ERBB2, AKT2 | T cell receptor signaling pathway | NFATC1, NFATC3, LAT, PIK3R5, LCK, AKT2 | Toll-like receptor signaling pathway | IRF5, TOLLIP, PIK3R5, IRF3, MYD88, AKT2 | Primary immunodeficiency | CIITA, RFX5, LCK | Measles | CCND3, FAS, PIK3R5, RACK1, IRF3, MYD88, AKT2 |
|
|